Many evidences showed that these receptors trigger the activation of the phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway, thus resulting in HCC occurrence and development. This evidence concerns the gene AKT1 and hepatocellular carcinoma.